Dow Up 0.11% Nasdaq Up 0.50%

Genetic Technologies Limited (GENE)

-NasdaqCM
0.66 Down 0.04(6.25%) Aug 29, 3:59PM EDT
Prev Close:0.71
Open:0.71
Bid:0.60 x 1000
Ask:0.70 x 4700
1y Target Est:2.50
Beta:-0.63
Next Earnings Date:N/A
Day's Range:0.66 - 0.72
52wk Range:0.60 - 2.54
Volume:335,751
Avg Vol (3m):260,477
Market Cap:12.81M
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GENE

Comparison

Symbol% ChgMkt Cap
GENEDown 6.25%12.81M
ABTDown 0.26%63.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.25
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback